Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.

LXRX · Nasdaq

Lexicon Pharmaceuticals, Inc. (LXRX) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Lexicon Pharmaceuticals, Inc. in 2026. The next earnings report is expected on November 11, 2026.

Earnings calendar

Next earnings date

11 Nov 2026

In 83 days

EPS estimate

-0.06

Revenue estimate

3.1M

Past earnings

06 Aug 2026
EPS actual
-0.07 (-39.4%)
estimate -0.05
Revenue actual
692.0K (-82.7%)
estimate 4.0M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
07 May 2026
EPS actual
0.00 (+100.0%)
estimate -0.03
Revenue actual
21.1M (+115.6%)
estimate 9.8M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
05 Mar 2026
EPS actual
-0.04 (+42.0%)
estimate -0.07
Revenue actual
5.5M (+74.8%)
estimate 3.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Michael S. Exton
Employees
103
IPO date
07 Apr 2000
ISIN
US5288723027
Website
lexpharma.com

Frequently asked questions

When does Lexicon Pharmaceuticals, Inc. (LXRX) next report earnings?

Lexicon Pharmaceuticals, Inc. (LXRX) is scheduled to report earnings on November 11, 2026.

What was Lexicon Pharmaceuticals, Inc.'s most recent earnings date?

Lexicon Pharmaceuticals, Inc. (LXRX) last reported earnings on August 6, 2026.

Where is Lexicon Pharmaceuticals, Inc. stock listed?

Lexicon Pharmaceuticals, Inc. (LXRX) is listed on Nasdaq.